Objective: To estimate the number of people in a prolonged disorder of consciousness (PDOC) who may need a formal best interests decision-making process to consider starting and/or continuing lifesustaining treatment each year in the population of a developed country. Method: Identification of studies on people with a PDOC giving information about incidence, and/or prevalence, and/or cause, and/or location of long-term care. Sources included systematic reviews, a new search of MEDLINE (April 2018), and a personal collection of papers. Validating information was sought from existing data on services. Results: There are few epidemiologically sound studies, most having bias and/or missing information. The best estimate of incidence of PDOC due to acute onset disease is 2.6/100,000/year; the best estimate of prevalence is between 2.0 and 5.0/100,000. There is evidence that prevalence in the Netherlands is about 10% of that in other countries. The commonest documented causes are cerebral hypoxia, stroke, traumatic brain injury, and tumours. There is some evidence suggesting that dementia is a common cause, but PDOC due to progressive disorders has not been studied systematically. Most people receive longterm care in nursing homes, but a significant proportion (10%-15%) may be cared for at home. Conclusion: Each year, about 5/100,000 people will enter a prolonged state of unconsciousness from acute onset and progressive brain damage; and at any one time, there may be 5/100,000 people in that state. However, the evidence is very limited in quality and quantity. The numbers may be greater.
Introduction
'If we develop a policy for making best interests decisions about starting or continuing gastrostomy feeding in people with a prolonged disorder of consciousness, how many patients should we expect to see within this policy each year?' This simple question has arisen in the context of developing such a How many patients in a prolonged disorder of consciousness might need a best interests meeting about starting or continuing gastrostomy feeding? policy in England and Wales. This article sets out the available evidence to give an approximate, 'good enough' estimate, which should help ensure that proposals proposed are feasible.
Decisions about starting, continuing, and stopping life-sustaining treatments such as gastrostomy feeding in people with a prolonged disorder of consciousness (PDOC) are controversial, [1] [2] [3] [4] and strong views are held. 5, 6 While many people say that personally, they would not want treatment continued, they are nevertheless less likely to support stopping treatment for others. 7, 8 A person's attitude to limiting life-sustaining treatment is influenced by religious beliefs and other cultural factors. 8, 9 Teams working in different intensive care units within one US state and system have different approaches, 10 and different countries have different approaches. 3, 8, 11, 12 To ensure a more consistent approach to some clinical situations, many countries are now developing policies based on evidence and, often, within an ethical and/or legal framework. This includes policies for people with a PDOC. 13 In England and Wales, legal 14, 15 and clinical guidance 16 has led to an expectation that a court needs to review all decisions about life-sustaining treatments in people with a PDOC, especially withdrawal of clinically assisted nutrition and hydration (gastrostomy feeding). Recent guidance may reduce the use of the court. 17 Policies on people with a PDOC need to balance practical considerations, including resources used, against ensuring that the process both is and is seen to be sound and fair, and open to review. The main determinant of the feasibility and cost of a policy is the number of people likely to fall within the remit of a policy. This article estimates the number of patients likely to be affected by a policy in England and Wales. The figures are likely to be similar in most developed countries.
Context in England and Wales
The first UK clinical guidance was published in 1993, 18 and the case of Tony Bland generated the first legal guidance. 14 , the difficulty in determining complete unawareness (i.e. the so-called vegetative state) was recognized; 19 in 2002, the minimally conscious state was defined; 20 and in 2003, further clinical guidance emerged. 21 Practice Direction 9E 15 updated English legal guidance in 2014 but was withdrawn in December 2017. These two clinical syndromes -vegetative state and minimally conscious state -are now referred to collectively as a PDOC. 16 In England and Wales, there is an urgent need to review both the legal and clinical guidance in relation to people in a state of a PDOC. This need arises from: Where possible, information on whether the state was secondary to an acute onset episode of brain damage or a progressive disease was extracted.
Supplementary Appendix 1 shows the search strategies and also lists all the papers used to show their origin within these processes. In addition, Supplementary Appendix 1 includes some unpublished information arising from a Freedom of Information request to the 213 clinical commissioning groups covering England in 2016, asking them to report how many people with a PDOC were being funded by the continuing healthcare fund; this is a fund that pays all care costs for eligible patients, and people with an acute onset PDOC should always receive this funding. 16 The data were used as a rough check on the validity of the estimated figures. Table 1 shows the five review papers found: the first published in 1994, 25 two published in 2014, 30, 31 a systematic review restricted to head injury, 32 and a narrative review. 29 These reviews reveal how few primary studies there are, especially of incidence, and the low the quality of most studies. Studies from the Netherlands all emphasize the low prevalence there (0.2/100,000), attributed to their particular clinical practice. 11, 12 Table 2 shows 16 individual studies which had a primary focus on disturbed consciousness (rather than on a specific cause of brain damage). It includes four recent studies not included in the other reviews. [44] [45] [46] [47] Table 3 shows information about studies that focussed on specific diseases causing a PDOC.
Results

Incidence
No studies examining the incidence arising from congenital or progressive causes were identified. Only three studies allow any estimate of incidence arising from all causes, 33, 41, 47 and one is methodologically too weak to be dependable. 41 The strongest study 47 suggests an incidence of new patients with an acute onset PDOC at four weeks after onset of 2.6/100,000/ year.
Studies on populations of people with traumatic brain injury suggest an incidence of Løvstad et al., 52 
2014, Norway
Prospective study of traumatic brain injury recruiting from all four major trauma centres in Norway. Follow-up at three months. Excluded people who also had alcohol/drug problems (n = 16), psychiatric disorder (n = 11), or progressive disorder (n = 19). Two year cohort. Population = 3.8 million.
359 patients identified over two years (2009, 2010) . PDOC: at three months seven and at 12 months four. Incidence = 0.09/100,000/ year at three months and 0.05/100,000/year at 12 months. Note that this is a very selected, very unrepresentative sample. 
Prevalence
Excluding studies from the Netherlands, the estimates of prevalence vary between 1.7 and 86.9/100,000. The one very high estimate 46 came from a study that found that 63% of people in the vegetative state were aged over 80 years and 65% had cerebrovascular disease. The remaining estimates are under 5.0/100,000. The reports give insufficient information about cause to determine how inclusive the samples were, but few studies record any people with progressive disease. Supplementary Appendix 1 shows the data from the Clinical Commissioning Groups in England, relating as far as is known to people with acute onset conditions. The data are poor, but one interpretation is that the prevalence of people with a PDOC being funded by the National Health Service is around 3.0/100,000.
Data relating to specific conditions
The multi-society task force clearly listed the great variety of causes of a PDOC, 25 classifying them into three groups: acute brain injuries, degenerative and metabolic disorders, and developmental malformations.
The studies in Table 2 illustrate the range of conditions associated with a PDOC. Among the acute conditions, the common conditions include cerebral hypoxia 26, 37, 45, 47 and stroke; 36, 38, 40 traumatic brain damage accounts for a minority of cases in most studies. 54 Other conditions of uncertain frequency include brain tumours 33, 34 and subarachnoid haemorrhage. 51 The importance of progressive and chronic conditions was known in 1991 26 and has been confirmed in those studies likely to identify progressive disorders. 40 Specific conditions identified occasionally include developmental disorders, 34 Parkinson's Disease, 40 and dementia, 40 with several studies reporting a range of other unspecified 'miscellaneous' diagnoses. Cases before the courts in England have also involved people with multiple sclerosis 55 and Huntington's disease. 56 PDOCs are most common in the elderly, 38, 46 and in one study the mean age was 78 years. 40 
Care setting
Almost all studies have concentrated upon hospitals and nursing homes, but the evidence shows that patients may be at home in the community; 36 in one study from Italy, 58/345 (17%) people were at home in the long-term care. 44 About 10% of cases in England funded by continuing healthcare were at home (Supplementary Appendix 1) .
Discussion
This review has demonstrated how little dependable and clinically useful published data there are about patients with PDOCs, either in relation to epidemiologically sound, descriptive matters or in relation to more practical matters such as service development and delivery.
Several factors limit the accuracy of the information presented here. Identifying relevant studies is difficult because there are no agreed specific terms for the clinical condition. In addition to the terms commonly used in England -vegetative state, minimally conscious state, and PDOCpapers may use many other specific terms, such as apallic syndrome, low-awareness state, and unresponsive wakefulness syndrome. Reassuringly, although a review using a much greater range of search terms in 2013 did find more studies, 31 most were of low quality and the estimates were similar to those presented here. The simple search used in this review found several new studies, most published after the two more detailed systematic reviews. 30, 31 It is unlikely that an existing but unidentified study will significantly alter the estimates given here.
Many of the reviewed studies suffer from weak methodology and/or poor description. The methods of case ascertainment are rarely well described and are usually weak. The basis for making a diagnosis is rarely well described. Operational definitions for the vegetative state and the minimally conscious state, or for prolonged, persistent, or permanent disorders are rarely specified and may differ between studies. Trying to distinguish differences between different categories of people within the spectrum of PDOC would not be possible on the basis of any published studies.
The population at risk is often not specified or easily identified. Most studies are restricted in their scope, considering only patients selected by diagnosis, severity, or other factors and/or only recruiting from selected settings. Furthermore, terms such as incidence and prevalence are used loosely and often incorrectly; they may also not be used when it would be appropriate to use them.
Bias may arise not only from the methodological weaknesses given above but also from preexisting, often unstated or unrecognized assumptions. For example, some people assume that the term, vegetative state, only applies to people who have an acute onset brain damage. Indeed, much of the research has focussed on traumatic brain injury, and many clinicians only think of head injury when discussing the problem.
The almost complete absence of any published research concerning people with, for example, multiple sclerosis, Huntington's disease, Alzheimer's disease, and other disorders probably reflects this bias. It is common experience that patients in the later stages of diseases such as Huntington's disease, multiple sclerosis, and Parkinson's disease may enter a state of PDOC, sometimes remaining alive in that state for many years.
The one outlier study suggesting a prevalence of 87/100,000 46 is notable for the large proportion of people aged over 80 years and the large proportion of people with stroke. While this could be secondary to a bias in the study, it is more likely that the research recruited from a population not normally considered. A high proportion of people with a PDOC was also found in the other study that specifically investigated older people. 40 Most studies have shown stroke to be a common cause, 25, 35, 37, 39 and stroke incidence increases with age. There is some evidence in support of this observed high rate. About 20% of all nursing home residents have had a stroke. 57 Furthermore, about 5% of nursing home residents receive gastrostomy feeding, 58 and it seems likely that a significant proportion of these have a PDOC secondary to stroke and/or dementia.
It therefore seems probable that the estimates of incidence and prevalence derived from the studies will be underestimates, probably quite significant underestimates, for the reasons detailed above:
• • Failure to include the whole population in most studies, and • • Failure to consider and identify patients with a PDOC from all causes, in all settings and of all ages.
The implications of the findings for any policy on making best interests decisions about life-sustaining treatment in patients who have a PDOC will now be considered; the process itself is discussed elsewhere. 23 
How many people enter a PDOC each year, surviving sufficiently long to require formal consideration of their best interests?
The best study available 47 suggests a figure of 2.6/100,000/year, but this will be an underestimate. It did not include people with progressive disorders, and the absence of any people with damage from tumours, infection, and other rare causes suggests that the recruitment may have been incomplete.
One way to check the validity of any epidemiological data is to compare it with data collected routinely in healthcare systems. Unfortunately, there is virtually no relevant routine health service data, which probably reflects a general lack of interest in people with severe disability requiring long-term support. Despite a recommendation that England and Wales should start registering all people entering a PDOC after acute brain damage, 16 there has been no action over four years. Some available data are considered below, including the data in Supplementary Appendix 1.
The UK Rehabilitation Outcomes Collaborative (UKROC) 59 did record the admission of 250 people with a PDOC to specialist rehabilitation centres in 2016; the number is increasing by 15% each year (Lynne Turner-Stokes; personal communication). An incidence of 2.5/100,000/year applied to the population of England and Wales (58 million) gives an annual incidence of 1450, and 250 represents 17%. This seems a high proportion of all acute cases likely to have occurred, given that significant areas of England and Wales lack centres, and most units have more people referred than can be admitted. Therefore, the true incidence may be higher and is unlikely to be lower.
A second source of information might also help. In the United Kingdom, all people who lack mental capacity to make healthcare decisions about accommodation may be made subject to a Deprivation of Liberty Safeguarding order; most people subjected to this order will also lack the capacity to make any complex healthcare decisions. In England, in 2014 and 2015, the rate of accepted applications for Deprivation of Liberty Safeguarding certificates was 122/100,000/year. 60 The rate in 2013 and 2014, when regulations were less all-encompassing, was approximately 7/100,000/year. A significant proportion of these applications will relate to people with progressive disorders and, although obviously not all subjects will have a PDOC, a significant proportion will be in a state of reduced awareness.
Assuming that the best evidence on incidence 47 is nonetheless an underestimate of the acute onset incidence, and assuming that the incidence of people entering a PDOC from a progressive cause is at least 2.5/100,000/year (given the probable high prevalence), it would seem reasonable to plan on the basis of 5/100,000/year entering a PDOC; this does not include patients obviously in the end-oflife phase (six months) of an illness. It would also seem sensible to assume that over the first 12 months, in patients remaining alive, a further two meetings (at a minimum) should occur.
How many people are there in the population with a PDOC?
The best estimate from research data is between 2.0-5.0/100,000. This is almost certainly an underestimate. As reported in the Supplementary Appendix 1, a Freedom of Information request was made to the 213 clinical commissioning groups covering England in 2016, asking them to report how many people with a PDOC were being funded by the continuing healthcare fund. Only 45 (21%) commissioners replied, and generally the quality of the information provided was very low. The prevalence rate for this selected subset of patients was between 1.7 and 3.85/100,000 in areas giving credibly accurate data.
Thus, planning on the basis of a prevalence of 5/100,000 is reasonably conservative, taking into account the observed high rates of prolonged unconsciousness in the elderly. 40, 46 A yearly review seems reasonable, after the first year.
A policy also need to recognize that, although the great majority of people in a PDOC are in nursing homes, an unknown but significant proportion of people live in their own homes; 10% would be a reasonable estimate. In England and Wales, both patients in nursing homes and patients at home are under the care of their general practitioner (family doctor). Therefore, any policy must recognize that patients will rarely be in a specialist hospital or rehabilitation setting beyond the first few weeks or months, and that general practitioners must play a central role in ensuring high-quality management.
Given that general practitioners are already overwhelmed with responsibilities transferred to them from hospital services and that they will have very little experience of people with a PDOC, the commissioners will need to commission a specialist service to assess and manage all patients with a PDOC in the community; this would best be provided by a neurological rehabilitation service. The role of the General Practitioner will be to identify any patient with a PDOC and to notify them to the responsible specialist rehabilitation service, who should keep a register so that yearly reviews are not forgotten.
Finally, the policy must consider that most people with a PDOC, if asked, would have said beforehand that they would want treatment stopped; only 14%-22% of the general public would definitely not want treatment stopped in the vegetative or minimally conscious state. 7 In a population of healthcare professionals, only around 15%-25% would want to be kept alive if in a vegetative or minimally conscious state. 8 The reasons likely to underlie these attitudes include a prioritization of autonomy, dignity, fair use of scarce resources, and freedom from distress, and pain above remaining alive. 7, 61 Thus, planning should occur on the basis that at least 80% of cases will require a serious consideration of treatment withdrawal. No assumptions about the likely decision should be made prior to holding the decision-making meeting; in other words, a uniform policy should apply to every meeting.
Thus, if one assumes Considering a population of 500,000, which is approximately the population considered in relation to hospital services, then the commissioners will need to fund specialist services to provide support to about: They should fund all at a level that allows a full and confident assessment of all aspects of each case, 23 so that decisions can be made without the need for further delay. They should also be funding, through continuing healthcare funding, the long-term care for 25 people at about £100,000/ year. This equates to £2,500,000/year/500,000 or £290,000,000/year for England and Wales.
Clinical messages
• • There is no dependable research into the clinical epidemiology of people with a PDOC; • • The best estimates are an incidence of 5/100,000/year, and a prevalence in most countries (excluding the Netherlands) of 5/100,000; • • The estimates are subject to considerable uncertainty and are likely to be low.
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